JeffreyDeanAlexisMD
Cardiology • Rochester, NYAdult Congenital Heart Disease, Heart Failure & Transplantation
Associate Professor, Medicine, University of Rochester School of Medicine & Dentistry
Dr. Alexis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box 679b
Rochester, NY 14642Phone+1 585-276-9761Fax+1 585-427-8718
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1995 - 1998
Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1995
Harvard Medical SchoolClass of 1992
Certifications & Licensure
NY State Medical License 1995 - 2025- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 8 citationsInhibition of MCP-1/CCR2 Signaling Does Not Inhibit Intimal Proliferation in a Mouse Aortic Transplant ModelJeffrey D. Alexis, Robert Pyo, Igor Chereshnev, Jonathan Katz, Barrett J. Rollins
Journal of Vascular Research. 2008-01-01 - 307 citationsClinical Outcomes for Peripartum Cardiomyopathy in North America Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy)Dennis M. McNamara, Uri Elkayam, Rami Alharethi, Julie B. Damp, Eileen Hsich
Journal of the American College of Cardiology. 2015-08-25 - 18 citationsPrevention of Fibrosis and Pathological Cardiac Remodeling by SalinomycinRyan M. Burke, Ronald A. Dirkx, Pearl Quijada, Janet K. Lighthouse, Amy Mohan
Circulation Research. 2021-05-28
Press Mentions
URMC to Lead $27M Heart Failure Medication StudyAugust 13th, 2024- UR Clinical Researchers Get $2.9 Million AwardNovember 15th, 2022
- New DoD Partnership Will Pave the Way for Therapeutic Advances for Chronic DiseasesNovember 2nd, 2022
- Join now to see all
Grant Support
- BCR And Ppargamma As Targets For Transplant ArteriopathyNational Heart, Lung, And Blood Institute2005–2009
- G Proteins As Targets For Transplant ArteriopathyNational Heart, Lung, And Blood Institute1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
